Alvotech (ALVO) — research page
US · us-cm-kg/NASDAQ/ALVO · as of 2026-11-08
Identity and listing
The issuer is Alvotech, listed on NASDAQ under ticker ALVO, with ISIN USL018001085. The LEI is not on the record, which holds no GLEIF record with the exact legal name in jurisdiction US-N4. The security type is non-operating entity (other), the segment is not on the record, the sector is 2836 Biological Products, (No Diagnostic Substances), and the jurisdiction is Luxembourg. The issuer is listed and not halted.
| field | value | source · read date |
|---|---|---|
| name | Alvotech | source · 2026-11-08 |
| exchange | NASDAQ | source · 2026-11-08 |
| ticker | ALVO | source · 2026-11-08 |
| ISIN | USL018001085 | source · 2026-10-09 |
| LEI | not on the record | |
| security type | Non-operating entity type (other) | source · 2026-11-08 |
| segment | not on the record | |
| sector | 2836 Biological Products, (No Diagnostic Substances) | source · 2026-11-08 |
| jurisdiction | Luxembourg | source · 2026-11-08 |
| status | listed, not halted | source · 2026-11-08 |
The disclosure read
The record holds 39 filings on 35 filing days in the window 2025-11-08 to 2026-11-08, comprising 33 results, 4 regulatory filings and 2 prospectuses. The median gap between filing days is 6.5 days. The latest filing is a results filing dated 2026-10-20, 19 days before the record date of 2026-11-08. On NASDAQ, the median cadence gap is 6.0 days, the median filings count is 52, and the median latency is 5.0 days across 4,359 issuers. In the sector, the median cadence gap is 5.5 days, the median filings count is 65.5, and the median latency is 4.0 days across 176 issuers.
| filings | median gap between filing days | days from latest filing to as-of | |
|---|---|---|---|
| this issuer | 39 | 6.5 | 19 |
| exchange median: NASDAQ (4359 issuers) | 52 | 6 | 5 |
| sector median: 2836 Biological Products, (No Diagnostic Substances) (176 issuers) | 65.5 | 5.5 | 4 |
| date | type | category | filing |
|---|---|---|---|
| 2026-10-20 | results | 6-K | 6-K — FORM 6-K |
| 2026-10-14 | results | 6-K | 6-K — FORM 6-K |
| 2026-10-07 | results | 6-K | 6-K — FORM 6-K |
| 2026-10-05 | results | 6-K | 6-K — FORM 6-K |
| 2026-08-31 | results | 6-K | 6-K — FORM 6-K |
window 2025-11-08 to 2026-11-08 · the node's disclosure lines, as get_filings serves them
Auditor
The auditor of record is not on the record, which carries no dei:AuditorName tag on the latest annual report cover, as foreign private issuers and older filings carry none. The auditor's location is not on the record. The record holds no auditor changes.
Events and halts
The record holds no listing, delisting or name change lines. The domicile change is not on the record, as EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, as the exchanges' tier transfers are not EDGAR filings. The halt flag is listed, not halted.
Orderability
The outcome is not determinable, because the chapter's orderability section carries no client categories and so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04.
rule acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability
Coverage
The record finds nine research houses named on the issuer's investor-relations page: Barclays, BofA Securities, Deutsche Bank, DNB Carnegie, Evercore ISI, IFS Reitun, Morgan Stanley, SEB and UBS.
| research house | analyst | source · read date |
|---|---|---|
| Barclays | Glen Santangelo | issuer page · 2026-11-11 |
| BofA Securities | Jason M. Gerberry | issuer page · 2026-11-11 |
| Deutsche Bank | Niall Alexander | issuer page · 2026-11-11 |
| DNB Carnegie | Arvid Necander | issuer page · 2026-11-11 |
| Evercore ISI | Umer Raffat | issuer page · 2026-11-11 |
| IFS Reitun | Joel Isal Joelsson | issuer page · 2026-11-11 |
| Morgan Stanley | Thibault Boutherin | issuer page · 2026-11-11 |
| SEB | Christopher W. Uhde | issuer page · 2026-11-11 |
| UBS | Ashwami Verma | issuer page · 2026-11-11 |
Open research
No openly published research notes were found on the record.
Licensed
Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.
| licensor | entitlement | title | date | source |
|---|---|---|---|---|
| none loaded |
As-of depth
The issuer's years sealed are 2021, 2022, 2023, 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12.
Sources
8 source pages are named on this page; every value above carries its own source page and read date in the numbers.
- 10.1
- https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange)
- 10.2
- https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin)
- 10.3
- https://data.sec.gov/submissions/CIK0001898416.json (identity.jurisdiction)
- 10.4
- https://mcp.us-cm-kg.ai/events/NASDAQ/ALVO (the disclosure lines)
- 10.5
- https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag)
- 10.6
- https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter)
- 10.7
- https://www.alvotech.com/analyst-coverage (coverage)
- 10.8
- https://mcp.us-cm-kg.ai/record/NASDAQ/ALVO (the record)
Read it by agent
The same page, signed and receipted: get_research at https://mcp.getissuer.ai/mcp with {"isin":"USL018001085"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:b954144c27cf7aed.